These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16787359)

  • 21. Fragment-based drug design: combining philosophy with technology.
    Bartoli S; Fincham CI; Fattori D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):422-9. PubMed ID: 17659483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-canonical modulators of nuclear receptors.
    Tice CM; Zheng YJ
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4157-64. PubMed ID: 27503683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
    Lather A; Sharma S; Khatkar A
    Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An ontology for pharmaceutical ligands and its application for in silico screening and library design.
    Schuffenhauer A; Zimmermann J; Stoop R; van der Vyver JJ; Lecchini S; Jacoby E
    J Chem Inf Comput Sci; 2002; 42(4):947-55. PubMed ID: 12132896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G Protein-Coupled Receptors: target-based in silico screening.
    Senderowitz H; Marantz Y
    Curr Pharm Des; 2009; 15(35):4049-68. PubMed ID: 20028321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational chemistry as an integral component of lead generation.
    Roche O; Guba W
    Mini Rev Med Chem; 2005 Jul; 5(7):677-83. PubMed ID: 16026314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and virtual screening of target libraries.
    Rognan D
    J Physiol Paris; 2006; 99(2-3):232-44. PubMed ID: 16459061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a new drug--from target identification to ultra-high-throughput screening.
    Golz S; Hüser J
    Clin Lab; 2007; 53(1-2):77-9. PubMed ID: 17323829
    [No Abstract]   [Full Text] [Related]  

  • 31. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemistry and biology of multicomponent reactions.
    Dömling A; Wang W; Wang K
    Chem Rev; 2012 Jun; 112(6):3083-135. PubMed ID: 22435608
    [No Abstract]   [Full Text] [Related]  

  • 34. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual Ligand Screening Using PL-PatchSurfer2, a Molecular Surface-Based Protein-Ligand Docking Method.
    Shin WH; Kihara D
    Methods Mol Biol; 2018; 1762():105-121. PubMed ID: 29594770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico fragment-based drug design.
    Konteatis ZD
    Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual compound screening in drug discovery.
    Stumpfe D; Ripphausen P; Bajorath J
    Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.